This is an audio transcript of the Behind the Money podcast episode: ‘An activist tried to take on Pfizer. Then things got ...

STIFF Nights promised to be an all-natural sex supplement to rival Viagra – but that wasn’t the whole truth. The little red pill with the sales pitch “Regain the Thunder”, was sold across ...

Two Summerville brothers are facing federal prison time after pleading guilty in a $35 million scheme to sell counterfeit Viagra.

Eli Lilly CEO David Ricks told investors this week that the sale of cheaper, knockoff versions of the company’s blockbuster ...

Viatris Inc.'s volatile stock performance, CEO's strategic focus on growth, and promising pipeline highlight potential for ...

In the case of Pfizer Ventures, she still sees a flood of pitches related to erectile dysfunction, given the pharma company's well-known blockbuster pill, Viagra. But Viagra now faces competition ...

A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the ...

Pfizer raised its full-year profit forecast after better-than-expected sales of its COVID-19 treatment helped it beat Wall Street estimates for third-quarter earnings on Tuesday.

In a pricey market, these stocks have been left behind, at just four to eight times earnings. Some are clear duds. A few look ...

Starboard Value, an activist investing group, took a position in Pfizer. It will now proceed to lobby for new initiatives, or perhaps new company leaders. Some of the activist's potential ...

The pharmaceutical company reported its third consecutive quarter with positive results.

Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...